2[1]Migdal M, Huppertz B, Tessler S, et al. Neuropilin-1 is a placenta growth factor- 2 receptor[J]. J Biol Chem, 1998,273(35):22272-22278.
3[2]Takanami I, Tanaka F, Hashizume T, et al. Vascular endothelial growth factor and its receptor correlate with angiogenesis and survival in pulmonary adenocarcinoma[J].Anti cancer Res, 1997,17(4A):2811-2814.
4[4]Yonemura Y, Fushida S, Bando E, et al. Lymphangiogenesis and the vascular endothelial growth factor receptor (VEGFR)-3 in gastric cancer[J]. Eur J Cancer, 2001,37(7):918-923.
5[9]Tang RF, Itakura J, Aikawa T, et al. Overexpression of lymphangiogenie growth factor VEGF-C in human pancreatic cancer[J]. Pancreas, 2001,22(3):285-292.
6[11]Latil A, Bieche I, Pesche S, et al. VEGF overexpression in clinically localized prostate tumors and neuropilin-1 overexpression in metastatic forms[J]. Int J Cancer, 2000,89(2):167-171.
7[12]Hazelton D, Nicosia RF, Nicosia SV. VEGF levels in ovarian cyst fluid correlate with malignancy[J]. Clin Cancer Res, 1999,5(4):823-829.
8[13]Gadducci A, Ferdeghini M, Fanucchi A, et al. Serum preoperative VEGF in epithelial ovarian cancer relationship prognostic variables and clinical outcome [J]. Anticancer Res, 1999,19(2B):1401-1405.
9[14]Giatromanolaki A, Sivridis E, Brekken R, et al. The angiogenic "vascular endothelial growth factor/flk-1 (KDR)receptor"pathway in patients with endometrial carcinoma [J]. Cancer, 2001,92(10):2569-2577.
10[16]Bellamy WT, Richter L, Frutiger Y, et al. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies [J]. Cancer Res, 1999,59(3):728-733.
6Okada K, Osaki M, Araki K, et al. Expression of hypoxiainducible factor (HIF-1 alpha), VEGF-C and VEGF-D in non-invasive and invasive breast ductal carcinomas [J]. Anticancer Res, 2005, 25 (4): 3003.
7Su JL, Shih JY, YenM L, et al. Cyclooxygenase-2 induces EP1 and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation: a novelmechanism of lymphangiogenesis in lung adenocar-cinoma [J]. Cancer Res, 2004, 64 (2): 554-564.
9Nakamura H,Izumoto Y,Kambe H,et al.Molecular cloning of complementary DNA for a novel human hepatoma-derived growth factor.Its homqlogy with high mobility group-1 protein [J].J Biol Chem,1994,269(40):25143-25149.
10Yano T,Tanikawa S,Fujie T,et al.Vascular endothelial growth factor expression and neovasculadsation in non-small cell lung cancer [J].Eur J Cancer,2000,36(5):601-609.